Beijing Tong Ren Tang Chinese Medicine schedules board meeting to review interim results, consider dividend

• Beijing Tong Ren Tang Chinese Medicine will hold a board meeting on Aug. 28, 2026 to review interim results for H1 2026.
• The board will also consider an interim dividend.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beijing Tong Ren Tang Chinese Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260814-12284706), on August 14, 2026, and is solely responsible for the information contained therein.